News | Angiography | March 14, 2025

SCAI Scientific Sessions 2025 to Feature Presentations on TAVR, PAD and PE 

Some of the late-breaking presentations will address topics such as transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE).

SCAI angiography

SCAI Scientific Sessions 2025 will take place May 1 to 3, at the Walter E. Washington Convention Center in Washington, DC.

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): 

  • “Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial” 
  • “The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation of the Neuroguard IEP® 3-in-1 Carotid Stent System with Integrated Embolic Protection. Stent Durability and Patency at 2 years”  
  • “A Prospective Study of the Next Generation AVENTUS Thrombectomy System: Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism” 
  • “Incidence and Gender-Based Comparison of Prosthesis-Patient Mismatch (PPM) in patients undergoing transcatheter aortic valve implantation (TAVI)”  
  • “Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population” 

For more information on the conference or to register to attend, please visit https://scai.org/scai-2025-scientific-sessions


Related Content

News | SCAI

Feb. 12, 2025 — A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type ...

Home February 18, 2025
Home
News | SCAI

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...

Home May 07, 2024
Home
News | SCAI

May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...

Home May 07, 2024
Home
News | SCAI

May 1, 2024 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific ...

Home May 01, 2024
Home
News | SCAI

June 1, 2023 — New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor ...

Home June 01, 2023
Home
News | SCAI

May 24, 2023 — The largest interventional study focused on pulmonary embolisms highlighted importance of rapid removal ...

Home May 24, 2023
Home
Feature | SCAI | Christine Book

May 23, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) welcomed its 46th President and 2023 ...

Home May 23, 2023
Home
News | SCAI

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

Home May 19, 2023
Home
News | SCAI

February 7, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) announced the second application ...

Home February 07, 2023
Home
News | SCAI

January 18, 2023 — the Society for Cardiovascular Angiography & Interventions (SCAI) announced four recipients of their ...

Home January 18, 2023
Home
Subscribe Now